Quality standards in mammography by unknown
40
R E V I E W  A R T I C L E
Quality Standards in Mammography
Ewa Wesołowska
Department of Mammography, Maria-Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Author’s address: Ewa Wesołowska, Department of Mammography, Maria-Skłodowska-Curie Memorial Cancer 
Center and Institute of Oncology, ul. W.K. Roentgena 5, 02-781 Warsaw, Poland, e-mail: ewawu7@wp.pl
 Summary
   The paper presents the incidence of breast cancer in Poland and the correlation between 5-year 
survival and the stage at which the tumors are detected, based on epidemiological data.
  Emphasizing the importance of population screening programs, the conditions that should be 
fulfilled by X-ray mammography – the main method of breast cancer detection – its role, limitations, 
approaches, and reasons for incorrect diagnoses are presented.
  The clinical signs of asymptomatic breast cancer are described and the techniques of an accurate 
X-ray mammography performance are discussed. The BI-RADS system developed by the American 
College of Radiology (ACR), is suggested to be a standard for mammography interpretation in the 
final conclusions and recommendations for further management.
  The sensitivity of the method enables detection of 80–90% clinically asymptomatic lesions, 
depending on a the breast structure. To obtain such results, high quality of examination is a must. 
Therefore, it is essential to implement a quality control program at each stage of the examination 
across all participating mammography labs.
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Breast cancer is one of the most serious health problems 
among the most common malignant tumors affecting 
women in the developed countries and the main cause of 
mortality in a female population between 25 and 60 years 
of age. Poland belongs to the countries with average mor-
bidity. However, as over 50% of newly diagnosed cases pre-
sent in advanced stages of the disease, the 5-year survival 
rates are low. There were almost 12 000 new cases repor-
ted in our country in 2002 and 5 thousand women died of 
breast cancer.
The studies conducted to date have demonstrated that 
significant effects on breast cancer- related mortality 
reduction (ca, 30%) have been obtained in most countries 
that introduced population screening programs, involving 
regular, periodically repeated mammography [1]. Clinical 
studies demonstrate a decrease in breast cancer- rela-
ted mortality rates among women aged 50–69 years if the 
examinations are repeated at 12–24-month intervals. On 
 account of the above finding, most organizations recom-
mend that period of time for regular mammography perfor-
mance. More frequent examinations carried out once a year 
are more beneficial for women at premenopausal age and 
belonging to high risk groups. Screening for breast cancer is 
expensive, however appropriately designed and performed 
screening tests may save the lives of many women.
X-ray mammography is the basic method of breast exami-
nation but it must fulfill certain conditions – at low radia-
tion dose images must be of very good quality that comply 
the established standards. Mammography is performed in 
2 basic projections – oblique (medio-lateral) and cranio-
caudal (CC). There are numerous additional projections, but 
targeted images with local compression and image enlarge-
ments are most commonly performed in practice. 
The description of mammography should contain an assess-
ment of observed morphological changes, conclusions 
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and recommendations for further management. American 
College of Radiology (ACR) developed the BIRADS (Breast 
Imaging Reporting and Data System), which should become 
a standard of mammography descriptions [2]. The final con-
clusions of mammography descriptions are divided accor-
ding to BI-RADS into the following categories:
•  category 0 – requires further investigations for category 
determination
•  category 1 – normal mammography 
•  category 2 – benign lesion 
•  category 3 – lesion probably benign 
•  category 4 – suspicious lesion 
•  category 5 – high probability of cancer 
•  category 6 – diagnosed breast cancer
•  Category 0 is usually determined in the assessment of 
screening results in the situations requiring further pro-
cedures for ultimate category determination. The recom-
mendations may include comparison with previous exa-
mination results, necessity of obtaining additional mam-
mography images, or ultrasound examination in case of 
a well-delineated tumor or high breast tissue density in 
women belonging to the risk group. In case of normal 
results (category 1) or typical benign lesions (category 2), 
routine control examinations at 1 – 2-year intervals sho-
uld be recommended. In case of probably benign lesions 
(category 3), the date of next control examination should 
be scheduled or additional examinations (USG, additio-
nal projections) ordered. The description of category 4 
indicates the possibility of cancer, thus a biopsy is recom-
mended in such cases. In case of category 5 lesions, the 
biopsy is indispensable. The recently introduced category 
6 concerns the cases of diagnosed breast cancers befo-
re radical treatment (second assessment of the diagnosed 
lesion, assessment of another lesion in the same or the 
other breast, or re-assessment of the lesion after neo-
adjuvant therapy).
The description, as a part of medical documentation, should 
include all the recommendations concerning the proposed 
accessory investigations, including the biopsy. A correctly 
performed mammography allows precise assessment of the 
breasts, good visualization of pathologic lesions and detec-
tion of impalpable lesions. The sensitivity of the method 
in detection of clinically asymptomatic lesions amounts to 
90%, and 80% in breasts with „dense” structure. The value 
of the method in differentiation of benign and malignant 
lesions is low. The character of the detected lesion is veri-
fied microscopically.
The most important task of mammary gland diagnostics is 
the diagnosis of cancer. Large size tumors pose no diagnos-
tic problems. The typical finding in mammography images 
is a round or oval mass of high density, irregular central 
portion, surrounded by a ring of processes – a spicular 
tumor. Such lesion type accounts for over 80% of palpable 
malignant lesions – most frequently invasive ductal car-
cinomas. Microcalcifications are important symptoms, 
allowing diagnosing of small, impalpable breast cancer. 
Mammography is the only reliable method of assessment of 
microcalcifications, starting from 50 μ size, which are often 
pre-invasive cancers.
Nearly 60% of pre-clinical cancers are diagnosed only on 
the basis of indirect signs such as focal distortion of breast 
architecture, asymmetry, tissue density or increase of 
a microcalcification size over a period of observation [3]. 
Indirect signs of malignancy include also such findings as 
thickening and/or skin collapse, nipple retraction, signs 
of breast edema, dilatation of a single duct or lymphade-
nopathy. In most cases, additional projections, targeted or 
enlarged images, USG and then microscopic verification 
are required. The verification methods are chosen at the 
radiologist’s discretion, and his/her choice should take into 
account both the types, size and location of the lesion, the 
breast size and structure, results of previous examinations, 
data obtained from anamnesis and clinical examinations, as 
well as the potential and limitations of particular diagnos-
tic procedures.
Correctly performed mammography enables precise breast 
assessment, good visualization of pathologic lesions and 
detection of impalpable ones. Although the effectiveness 
of mammography has been proven, the examination is not 
ideal with respect to sensitivity and specificity. The per-
centage of false negative results ranges from 3% to 30%, 
both among patients with clinical symptoms and among 
asymptomatic subjects undergoing screening examinations 
[4]. The false negative results may be due to technical 
errors or inadequate quality control. Another reason for 
false results is a dense glandular structure of the breasts, 
which may obscure the presence of focal lesions. In other 
cases, the images visualize subtle signs of malignancy 
overlooked by the radiologist. A low percentage of cancers 
is completely invisible in radiographic images or shows 
the features of a benign lesion. False positive results are 
obtained because of similar technical limitations, or are 
due to increased vigilance associated with medical and 
legal problems resulting from a failure to diagnose a malig-
nant tumor. Diagnostic errors may, on the one hand, cause 
a failure to diagnose cancer, and, on the other hand, it 
should be remembered that a vast majority of the screened 
population is healthy and will not develop breast cancer in 
future, either. 
It should be emphasized that both diagnostic and screen-
ing mammography must be of high quality. Therefore, it 
is very important to implement and maintain a quality 
assurance program [5]. This program should concern each 
stage of mammography and should constitute an internal 
part of each examination center activity. This will ensure 
high and repeatable technical quality and an appropriate 
level of interpretation. A mammography laboratory should 
be assessed with respect to the equipment, its correct use, 
and qualification of the personnel: radiologists, technicians, 
medical physicists. Each member of the staff should be 
assigned to specific tasks in the quality assurance program, 
and the radiologist should be responsible for its effective 
implementation.
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